Visualizing CAR-T cell Immunotherapy Using 3 Tesla Fluorine-19 MRI

PURPOSE: Chimeric antigen receptor (CAR) T cell cancer immunotherapies have shown remarkable results in patients with hematological malignancies and represent the first approved genetically modified cellular therapies. However, not all blood cancer patients respond favorably, serious side effects ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubois, Veronica P., Sehl, Olivia C., Foster, Paula J., Ronald, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983548/
https://www.ncbi.nlm.nih.gov/pubmed/34786668
http://dx.doi.org/10.1007/s11307-021-01672-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983548/
https://www.ncbi.nlm.nih.gov/pubmed/34786668
http://dx.doi.org/10.1007/s11307-021-01672-3

Ejemplares similares